In June 2015, the US Food and Drug Administration (US FDA) ruled to ban trans fat from hundreds of foods. Food manufacturers, restaurants and others have until June 2018 to comply. While many have already been working to phase out trans fat from their products, others don’t think it will be that easy and are petitioning for some continued use.
The ban, as well as a business’ continued use of trans fat in products, could pose potential risks and XL Catlin’s Enterprise Risk Management and Casualty Risk Engineering teams continue to monitor the potential, watching for possible litigation against food/beverage manufacturers, distributors, suppliers and advertisers, as well as potential product recall actions as a result of the recent FDA decision. Trans fat continues to be an emerging risk that XL Catlin is watching.
E-cigarettes have been on our watchlist of emerging risks for the past several years. A recent outbreak of severe pulmonary disease in the U.S., coupled with reports of deaths suspected to be linked to vaping, have given the issue an even greater focus from regulators and policymakers.
In March this
Too many businesses realize the value of their insurance coverage only after the fact, after they lose something first. That means too many are missing out on reaping the full value of their insurance programs. At the same time, that means that we, as insurers, need to step up our game to make sure
Making inclusion work: putting words into practice
September 23, 2019
I have spent my entire career – more than 25 years and counting – in insurance, and I’m proud to see how the industry has changed over that time to become more open and diverse. But we cannot rest on our laurels; there is still a long way to go.
I began my working life as an underwriter and have worked